Pfizer/BioNTech vaccine approved for children by Swiss regulator
Keystone / Pablo Gianinazzi
The Swiss medical regulator has approved the use of Pfizer/BioNTech’s Covid-19 vaccine for children aged five to 11. However, the Federal Vaccination Commission has yet to recommend extending the immunisation campaign to this group.
This content was published on
2 minutes
swissinfo.ch/dos
Español
es
Suiza aprueba la vacuna de Pfizer/BioNTech para niños
“The clinical trial results show that the vaccine is safe and effective in this age group,” wrote Swissmedic on FridayExternal link. It said an ongoing study involving more than 1,500 people showed “almost complete protection against serious illness” caused by Covid-19 among those aged five to 11 and that side effects tended to occur less frequently than in adolescents or adults.
These side effects – slightly more frequent after the second dose – can include pain at the point of injection, tiredness, and occasionally headaches, joint pain, or fever.
The regulator recommends two doses of the vaccine, three weeks apart, but at just one-third the strength of a normal adult dose.
However, a recommendation by the Federal Vaccination Commission would be needed before the national immunisation strategy would be updated to include this age group, Swissmedic told the Keystone-SDA news agency.
As of Friday evening, the website of the Federal Office of Public Health indicated that “currently there are no plans to vaccinate children under 12”.
Moderna waiting
Meanwhile, Moderna’s Spikevax vaccine is still under review by Swissmedic for use on children, with no decision yet taken. The Janssen viral vector vaccine, the third being used on adults in Switzerland, has not been submitted for consideration on children.
Overall, despite efforts by authorities to spur interest, the Swiss are still among the most reluctant to vaccinate in Western Europe; as of Friday, some 68% of the population had received at least one vaccine dose, amounting to around 78% of the adult (aged 19 and above) population.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
Swiss authorities keep close eye on West Nile fever in Italy
This content was published on
Authorities are keeping a close eye on the situation after the death toll in Italy due to the disease has risen to seven.
Swiss authorities aim to keep negotiating with US on tariffs
This content was published on
A day after the US tariff shock, Swiss officials are still in contact with Washington. One economist meanwhile warns of a hit to Swiss jobs.
Bern biodiversity project brings boost for forest bees
This content was published on
More sunlit areas in forests can boost the number of wild bees – both in overall terms and in terms of species diversity.
Swiss president kicks off National Day celebrations on Rütli meadow
This content was published on
Several hundred people gathered on the Rütli in central Switzerland at midday on Friday to celebrate the national Swiss holiday, before Karin Keller-Sutter addressed the crowd.
US sets deadline for Novartis and other pharma firms to lower prices
This content was published on
US President Donald Trump says he has sent letters to Swiss giant Novartis and other pharma firms calling for lower drug prices in the United States – or face retaliation.
Around 25,000m3 of rockfall registered in Swiss village of Brienz
This content was published on
More rock has come loose in the eastern Swiss village of Brienz than initially assumed following rainfall last weekend, said a new situation report published on Friday.
Swiss government reacts with ‘great regret’ to new US tariffs
This content was published on
The Swiss government says it will continue to strive for a negotiated solution after the United States imposed 39% tariffs on the Alpine country.
Switzerland testing AI tools to make scarecrows more effective
This content was published on
The Swiss agricultural research centre Agroscope is testing an AI system to more effectively prevent damage to agricultural crops caused by crows and rooks.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Government moots more Covid measures, including partial closures
This content was published on
A week after tightening certificate and mask-wearing rules, the government has proposed new measures to ease Covid-19 pressure on hospitals.
Study shows benefit of regular classroom ventilation
This content was published on
A Swiss study has found that poorly ventilated school classrooms record up to six times as many Covid-19 cases compared with those which are regularly aired.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.